Showing results (221-230 of 236) with videos related to
Sort By:
Pageof 24
Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.Cardiovascular Research|August 26, 1998
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantationL Gullestad, G Haywood, H Aass, et al.Circulation|April 16, 1998
Elevated circulating levels of C-C chemokines in patients with congestive heart failureP Aukrust, T Ueland, F Müller, et al.Archives of Internal Medicine|December 22, 1999
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival StudyS M Haffner, C M Alexander, T J Cook, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1997
Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countriesP S Hansen, J C Defesche, J J Kastelein, et al.Computers and Biomedical Research, an International Journal|February 1, 1990
Predicting 1-year outcome following acute myocardial infarction: physicians versus computersE A Gilpin, R A Olshen, K Chatterjee, et al.The American Journal of Medicine|May 10, 2001
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjectsK B Holven, T Holm, P Aukrust, et al.Atherosclerosis|May 1, 1997
A common W556S mutation in the LDL receptor gene of Danish patients with familial hypercholesterolemia encodes a transport-defective proteinH K Jensen, H Holst, L G Jensen, et al.Journal of Internal Medicine|January 4, 2012
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*S H Nymo, T Ueland, E T Askevold, et al.Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.Pageof 24